Combined BCL2 and BTK inhibition in CLL demonstrates efficacy after monotherapy with both classes
Jonathan Hyak, Ying Huang, Kerry A. Rogers, Seema A. Bhat, Michael R. Grever, John C. Byrd, Adam S. Kittai, Dan Jones, Cecelia Miller, Jennifer A. Woyach
Topics & Concepts
Bruton's tyrosine kinaseMedicineInternal medicinePharmacologyCancer researchReceptorTyrosine kinaseChronic Lymphocytic Leukemia ResearchAdvanced Breast Cancer TherapiesLymphoma Diagnosis and Treatment